Cover Image

Role of Calcimimetics in Treating Bone and Mineral Disorders Related to Chronic Kidney Disease

Renal osteodystrophy is common in patients with chronic kidney disease and end-stage renal disease and leads to the risks of fracture and extraosseous vascular calcification. Secondary hyperparathyroidism (SHPT) is characterized by a compensatory increase in parathyroid hormone (PTH) secretion in re...

Full description

Saved in:

Bibliographic Details
Main Authors:	Yi-Chou Hou (Author), Cai-Mei Zheng (Author), Hui-Wen Chiu (Author), Wen-Chih Liu (Author), Kuo-Cheng Lu (Author), Chien-Lin Lu (Author)
Format:	Book
Published:	MDPI AG, 2022-07-01T00:00:00Z.
Subjects:	article
Online Access:	Connect to this object online.
Tags:	Add Tag No Tags, Be the first to tag this record!

Similar Items

Limited usefulness of calcimimetics for secondary hyperparathyroidism in non-dialysis chronic kidney disease
by: Fizza Abbas, et al.
Published: (2019)

Refractory tertiary hyperparathyroidism after calcimimetics and delayed parathyroidectomy in a kidney transplant recipient
by: Ekamol Tantisattamo, et al.
Published: (2012)

The impact of metformin in chronic kidney disease-mineral and bone disorder
by: Rohollah Masumi, et al.
Published: (2021)

Effect of mobile APP in the management and application of mineral and bone disorder in dialysis patients of chronic kidney disease
by: Gulimire Muhetaer, et al.
Published: (2024)

Indoxyl-Sulfate-Induced Redox Imbalance in Chronic Kidney Disease
by: Chien-Lin Lu, et al.
Published: (2021)

Cardiovascular Risk and Mineral Bone Disorder in Patients with Chronic Kidney Disease
by: Hagen Staude, et al.
Published: (2013)

Uremic Toxin Indoxyl Sulfate Impairs Hydrogen Sulfide Formation in Renal Tubular Cells
by: Chien-Lin Lu, et al.
Published: (2022)

Mineral bone disorders and kidney disease in hospitalized children with sickle cell anemia
by: Anthony Batte, et al.
Published: (2023)

Myocardial Remodeling in Early Chronic Kidney Disease-Mineral and Bone Disorder Model with Low Bone Turnover
by: Evdokia Bogdanova, et al.
Published: (2023)

Artificial intelligence-guided precision treatment of chronic kidney disease-mineral bone disorder
by: Adam E. Gaweda, et al.
Published: (2022)

Management of chronic kidney disease-mineral and bone disorder: Korean working group recommendations
by: Eunah Hwang, et al.
Published: (2015)

Mineral and Bone Disorder in Children with Chronic Kidney Disease Stage I to V (Predialysis)
by: Joo Hoon Lee, et al.
Published: (2014)

Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD), from Bench to Bedside
by: Kosaku Nitta, et al.
Published: (2023)

Deep ocean mineral water accelerates recovery from physical fatigue
by: Hou Chien-Wen, et al.
Published: (2013)

Why do we need regional chronic kidney disease-mineral bone disorders guidelines?
by: Hyung Jung Oh, et al.
Published: (2018)

Diagnosis and Management of Chronic Kidney Disease-Mineral Bone Disease in Children
by: Jin-Soon Suh
Published: (2020)

Resveratrol Butyrate Ester Protects Adenine-Treated Rats against Hypertension and Kidney Disease by Regulating the Gut-Kidney Axis
by: Chien-Ning Hsu, et al.
Published: (2021)

Role of SIRT3 in bone homeostasis and its application in preventing and treating bone diseases
by: Ke Xu, et al.
Published: (2023)

Mineral and bone disorders in peritoneal dialysis
by: imane Houem, et al.
Published: (2022)

Editorial: Mineral and Bone Disorder in CKD
by: Nikoleta Printza, et al.
Published: (2022)

Assessment of CYP‐Mediated Drug Interactions for Evocalcet, a New Calcimimetic Agent, Based on In Vitro Investigations and a Cocktail Study in Humans
by: Kazuya Narushima, et al.
Published: (2019)

The Effects of Indoxyl Sulfate and Oxidative Stress on the Severity of Peripheral Nerve Dysfunction in Patients with Chronic Kidney Diseases
by: Yun-Ru Lai, et al.
Published: (2022)

Does Physical Exercise Ameliorate Chronic Kidney Disease-Related Complications? The Case of Anaemia and Chronic Kidney Disease-Mineral Bone Disorder
by: Filippo Aucella, et al.
Published: (2024)

Effectiveness of molnupiravir for treating COVID-19 in patients with psychiatric disorders
by: Ting-Hui Liu, et al.
Published: (2024)

Taking Sleeping Pills and the Risk of Chronic Kidney Disease: A Nationwide Population-Based Retrospective Cohort Study
by: Chen-Yi Liao, et al.
Published: (2021)

The Impact of Bone Mineral Biomarkers on Cardiac Dysfunction in Predialysis Chronic Kidney Disease Children
by: Safaa Ali, et al.
Published: (2021)

Functional Proteins Involved in Regulation of Intracellular Ca2+ for Drug Development: The Extracellular Calcium Receptor and an Innovative Medical Approach to Control Secondary Hyperparathyroidism by Calcimimetics
by: Nobuo Nagano, et al.
Published: (2005)

Mayer-Rokitansky-Küster-Hauser syndrome with leiomyomas in a rudimentary uterus treated with transvaginal NOTES
by: Chih-Yi Yang, et al.
Published: (2021)

Potential effect of pharmaceutical care to improve outcomes in patients with chronic kidney disease-mineral bone disorder in Sulaimani dialysis centers
by: Hawkar Qadir Baiz, et al.
Published: (2020)

Pharmacokinetics, Pharmacodynamics, and Safety of Evocalcet (KHK7580), a Novel Calcimimetic Agent: An Open-Label, Single- and Multiple-Dose, Phase I Trial in Healthy Chinese Subjects
by: He X, et al.
Published: (2024)

Assessment of bone mineral density by dual x-ray absorptiometry in dermatological patients treated by corticosteroids
by: Salem Dorria, et al.
Published: (2010)

Effect of Bone Mineral Density on Functional and Radiological Results in Conservatively Treated Distal Radius Fractures
by: Tolga Onay, et al.
Published: (2015)

Longitudinal changes in bone mineral density of healthy elderly women in southern Taiwan
by: Chung-Hwan Chen, et al.
Published: (2013)

Anticonvulsants and Bone Mineral Density
by: J Gordon Millichap
Published: (1995)

Correlation of glomerular filtration rate and fibroblast growth factor-23 levels in chronic kidney disease; sub analysis chronic kidney disease-mineral and bone disorder study
by: Akiko Syawalidhany Tahir, et al.
Published: (2024)

Bone Mineral Density in Iranian Kidney Graft Recipients and Its Relation to Biochemical and PTH Serum Levels
by: M Mahdavi, et al.
Published: (2004)

Bone Mineral Density in Iranian Kidney Graft Recipients and Its Relation to Biochemical and PTH Serum Levels
by: M Mahdavi, et al.
Published: (2004)

Impact of kidney transplantation on serum bone mineral levels and anemia - a cohort study on Egyptian children
by: Amal Hagras, et al.
Published: (2023)

Association between parity and bone mineral density in postmenopausal women
by: Yimei Yang, et al.
Published: (2022)

Risk of Skin Cancer among Patients with Chronic Kidney Disease Treated with Ultraviolet B Phototherapy for Uraemic Pruritus: A Nationwide Cohort Study
by: Mei-Ju Ko, et al.
Published: (2021)